1. Home
  2. PRPO vs GRNQ Comparison

PRPO vs GRNQ Comparison

Compare PRPO & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • GRNQ
  • Stock Information
  • Founded
  • PRPO N/A
  • GRNQ 2013
  • Country
  • PRPO United States
  • GRNQ Malaysia
  • Employees
  • PRPO N/A
  • GRNQ N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • GRNQ EDP Services
  • Sector
  • PRPO Industrials
  • GRNQ Technology
  • Exchange
  • PRPO Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • PRPO 8.8M
  • GRNQ 7.8M
  • IPO Year
  • PRPO N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • PRPO $4.69
  • GRNQ $0.87
  • Analyst Decision
  • PRPO
  • GRNQ
  • Analyst Count
  • PRPO 0
  • GRNQ 0
  • Target Price
  • PRPO N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • PRPO 5.7K
  • GRNQ 12.7K
  • Earning Date
  • PRPO 08-15-2024
  • GRNQ 08-09-2024
  • Dividend Yield
  • PRPO N/A
  • GRNQ N/A
  • EPS Growth
  • PRPO N/A
  • GRNQ N/A
  • EPS
  • PRPO N/A
  • GRNQ 0.09
  • Revenue
  • PRPO $15,812,000.00
  • GRNQ $3,498,328.00
  • Revenue This Year
  • PRPO $75.18
  • GRNQ N/A
  • Revenue Next Year
  • PRPO N/A
  • GRNQ N/A
  • P/E Ratio
  • PRPO N/A
  • GRNQ $9.70
  • Revenue Growth
  • PRPO 61.64
  • GRNQ N/A
  • 52 Week Low
  • PRPO $4.31
  • GRNQ $0.72
  • 52 Week High
  • PRPO $8.99
  • GRNQ $1.90
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 34.21
  • GRNQ 37.68
  • Support Level
  • PRPO $4.73
  • GRNQ $0.96
  • Resistance Level
  • PRPO $5.14
  • GRNQ $1.08
  • Average True Range (ATR)
  • PRPO 0.34
  • GRNQ 0.08
  • MACD
  • PRPO -0.02
  • GRNQ -0.01
  • Stochastic Oscillator
  • PRPO 31.40
  • GRNQ 0.00

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: